FDAFDA · Food and drugs·Recall number D-0389-2024
Digoxin Tablets, USP 125mcg, (0.125 mg), 1000-count bottle, Rx Only, Manufactured by: Novitium Pharma LLC., 70 Lake Drive, East Windsor, New Jersey 08520, NDC 70954-201-20
Published March 27, 2024 · Recall initiated: March 4, 2024
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Cross Contamination with Other Products:(mycophenolate mofetil).
What to do
Voluntary: Firm initiated · Letter
Recall details
- Brand
- DIGOXIN
- Manufacturer
- Novitium Pharma LLC
- Distributor
- Nationwide in the USA
- UPC
- 0370954201106
- Lot
- Lot #: M23172A, Exp 01/31/2025
- Risk classification
- Class III
- Area (FDA)
- drug
- Country
- United States
Sell products like this?
Recalert watches your whole catalog for recalls like this one, automatically.